Company intelligence / Profile preview

Univercells

Gosselies, Wallonia, Belgium
Ownership
Private
Employees
~400
Development stage
Other
01

Overview

Univercells is a Belgian biotechnology company dedicated to making biologics accessible and affordable globally through innovative bioprocessing technologies. The company focuses on bioprocessing intensification, utilizing its proprietary platforms to reduce the footprint and cost of manufacturing vaccines, viral vectors, and monoclonal antibodies. Through its various subsidiaries and affiliates, such as Quantoom Biosciences and N-BIOTEK, Univercells provides end-to-end solutions ranging from discovery to large-scale production. Their mission is to enable biologics for all by supporting local manufacturing in low- and middle-income countries. The company operates as a group of specialized entities, including the CDMO Exothera, to address different segments of the biopharmaceutical value chain.

Therapeutic areas
Infectious DiseasesOncology
Modalities
VaccinemRNA-based drugsViral vectorMonoclonal antibodyBiologic
Industry
Biotech
02

Partnerships

Bill & Melinda Gates FoundationSyngeneSerum Institute of IndiaGaviCEPI

Beyond the preview

Go deeper on Univercells.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Univercells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call